Molecular Partners pursues an isotope-agnostic strategy for its pipeline of targeted alpha therapeutics. The versatility of DARPins allows interchangeability of alpha isotopes, including 212 Pb and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results